•p In this issue, Augustin et al.
[1] report a positive association between the glycemic index and glycemic load of the diet and breast cancer risk. If these results reflect a causal association, the implication would be that breast cancer risk might be lowered by reducing the intake of foods with a high glycemic index such as white bread, potatoes, cakes and confectionery, and replacing these sources of carbohydrates with lower glycemic index foods such as whole-grain cereals, pasta and fruit The possible effects of diet on breast cancer risk are a long-standing enigma for epidemiologists The main basis for the hypothesis that diet may affect breast cancer risk is the ecological observation that breast cancer rates are up to six times higher in Western countries with a high intake of animal products and refined carbohydrate foods than in countries with a much lower intake of these foods. Most attention has been given to the hypothesis that high fat diets may increase breast cancer risk, but the best data available to date offer little support to this hypothesis [2, 3] These findings have led to waning interest in fat and increasing interest in other features of a Western diet, and one of the more recent hypotheses formulated is that related to refined carbohydrates, glycemic index, and insulin As summarized by Augustin et al [1] , the basis of the insulin hypothesis is that diets rich in certain types of carbohydrate lead to relatively high blood levels of glucose and insulin and that these factors in turn increase breast cancer risk, perhaps due to a direct mitogenic effect of insulin or related growth factors [4-6] The concept of the glycemic index was introduced by Jenkins et al. in 1981 [7] The glycemic index ranks carbohydrate foods according to their effects on postprandial glycemia, with the index expressed in proportion to the effect of an equal weight of carbohydrate consumed as glucose (sometimes white bread is used as an alternative standard, but the resulting ranking of foods is the same). Foods with a low glycemic index include legumes and fruits. The majority of foods rich in starch which are commonly consumed in Western countries have a high glycemic index -including most types of bread, potatoes and breakfast cereals; the only common cereals with a moderate or low glycemic index are pasta (especially if eaten 'al dente'), many types of rice, and some breads containing intact grains. Perhaps surprisingly, ordinary sugar (sucrose) has a lower glycemic index than white bread, because the fructose component of sucrose has a small glycemic effect.
The glycemic index is expressed per unit of carbohydrate within the diet; glycemic load is a related measure, which is simply the glycemic effect and therefore insulin demand of the whole diet. It might therefore be expected that the impact of the carbohydrate content of the diet on disease risk would be related more to the glycemic load of the diet, rather than the glycemic index. Austin et al.
[1] examined both indices, and observed slightly stronger associations of breast cancer risk with glycemic index than with glycemic load.
There are as yet no other studies with which to directly compare the results of Augustin et al., since previous studies of diet and breast cancer have not focussed on glycemic index. Some studies have found a reduction in breast cancer risk associated with a high intake of fibre, which can reduce the glycemic impact of the diet, but other studies of fibre have been negative and the overall results are inconsistent [8] . Augustin et al. themselves have also recently published on glycemic index and colorectal cancer risk within the same study framework [9] . For this cancer, they again observed increases in risk associated with both glycemic index and glycemic load, but the size of the risks was substantially higher than for breast cancer (relative risks in the highest quintile of about 1.7 for colorectal cancer vs. about 1 3 for breast cancer), suggesting that the dietary factors they studied may be more closely related to colorectal cancer than to breast cancer.
More can be said about the consistency of the insulin hypothesis with the wider epidemiology of breast cancer. In particular, consideration of the associations of breast cancer risk with diabetes and with obesity is relevant, since both these conditions are associated with insulin. The possible association between diabetes and breast cancer has been investigated by many studies. The findings have not provided consistent evidence of a positive association between diabetes and breast cancer risk [5, 6] . Moreover, at the population level the epidemiology of the two diseases is rather different, both increase with Westernization, but diabetes is very common in some population groups which do not have high rates of breast cancer In Britain, for example, diabetes rates among men and women of South Asian origin are much higher than the rates among the white population, whereas breast cancer rates among British South Asian women are lower than among white women [10-12] Although insulin levels fall in advanced diabetes, insulin levels are generally raised in early diabetes and hyperinsulinemia is likely to be common among populations with high diabetes rates, for example, insulin levels have been shown to be higher among nondiabetic British South Asians than among British whites [10, 13]. The non-concordance of the epidemiology of breast cancer and diabetes at the population level might imply that insulin is not a major risk factor for breast cancer A characteristic of obesity is an elevated fasting plasma insulin and an exaggerated insulin response to an oral glucose load [14] The relationship of obesity with breast cancer risk is complex and has implications for the insulin hypothesis. In premenopausal women breast cancer risk does not increase with increasing body mass index, indeed some studies have found that breast cancer risk is relatively low in obese premenopausal women [15] . In contrast, among postmenopausal women there is a linear association between body mass index and breast cancer risk, with obese women having a risk about 50% higher than that of lean women (this relationship is most clearly seen after about age 60, [16] ). These relationships may be explained by the effects of obesity on estrogens. Estradiol is the most potent endogenous estrogen, and several prospective studies have now demonstrated that endogenous estradiol in postmenopausal women is positively associated with breast cancer risk [17] . Among postmenopausal women, obesity increases estradiol production by aromatization of androgens, and obese postmenopausal women have estradiol levels about twice as high as those in lean women [18] . This association is not seen among premenopausal women, among whom estradiol is predominantly produced by the ovaries and is subject to control through feedback Thus the associations of obesity with breast cancer risk parallel the associations of obesity with estrogens This is not the case for insulin -obese premenopausal women have high insulin levels, but do not have an increased risk for breast cancer.
These inconsistencies in the insulin hypothesis for breast cancer do not disprove the hypothesis, since the etiology of breast cancer may be very complex and insulin may play a role However, thought should also be given to alternative interpretations of data such as those provided by Augustin et al. In essence, they have observed that the women in their study who had breast cancer reported higher consumption of refined carbohydrate foods such as white bread and sugar than the control women The authors analysed their data carefully and concluded that the association of breast cancer risk with glycemic index remained after adjusting for other relevant dietary factors, but in view of the wellknown limitations of dietary assessment methods and food tables it is difficult to be confident that the association might not be explained by other dietary factors How can this topic be resolved? Disentangling the effects of different dietary factors is extremely difficult, but testing the specific hypothesis that hypennsulinemia increases breast cancer risk should be relatively straightforward. Prospective studies with stored blood can be used to measure either fasting insulin itself or C-peptide, a longer-term marker of insulin levels So far only one prospective study has published on C-peptide and breast cancer risk, and did not find any association [19] , a second study on plasma glucose also did not observe any association with breast cancer risk [20] . Two casecontrol studies did observe that either C-peptide [4] or insulin [21] levels were higher in women with breast cancer than controls, but these differences were not observed in a third case-control study [22] , and differences in case-control studies could be due to an effect of the disease. Over the next few years other prospective studies can be expected to publish on this topic, and these studies should establish whether circulating insulin plays a significant role in the etiology of breast cancer. 
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